Lipoatrophic diabetes: a new variant characterized by tapeto-retinal degeneration, late onset generalized lipoatrophy, insulin-resistant hyperglycemia and hyperlipidemia.
D000273:Adipose Tissue / Q000473:pathology; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001786:Blood Glucose; D002747:Chlorpropamide / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D003864:Depression, Chemical; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000378:metabolism; D003927:Diet, Diabetic; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005951:Glucose Tolerance Test; D005990:Glycerol / Q000097:blood; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology; D007328:Insulin / Q000097:blood; D008055:Lipids / Q000097:blood; D008060:Lipodystrophy / Q000209:etiology; D008297:Male; D012162:Retinal Degeneration / Q000209:etiology; D013268:Stimulation, Chemical; D013997:Time Factors
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D008055:Lipids; D002784:Cholesterol; D005990:Glycerol; D002747:Chlorpropamide